2BB score and signals
Maze Therapeutics, Inc.’s current 2BB score is 52 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 55 | Moderate |
| Momentum | 32 | Weakening |
| Financial strength | 27 | Weak |
| Quality | 93 | Very Strong |
| Risk | 42 | Moderate |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 2017 |
| Employees | 141 |
| 52-week range | $21.95 – $53.65 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-22 | — | -0.845 | — | $0.00 |
| 2026-11-05 | — | -0.8004 | — | $0.00 |
| 2026-08-18 | — | -0.7487 | — | $2.04M |
| 2026-05-20 | — | -0.5565 | — | $9.47M |
Related companies
2BBBullish & Bearish